This announcement is a separate document:
復宏漢霖：內幕消息公告 - 國家藥品監督管理局批准漢斯狀（斯魯利單抗注射液）聯合化療用於局部晚期或轉移性非鱗狀非小細胞肺癌(NSCLC)的一線治療新適應症的上市註冊申請(NDA)
HENLIUS: INSIDE INFORMATION ANNOUNCEMENT - NEW DRUG APPLICATION (NDA) FOR NEW INDICATION OFHANSIZHUANG (SERPLULIMAB INJECTION) IN COMBINATION WITHCHEMOTHERAPY FOR THE FIRST-LINE TREATMENT OF PATIENTSWITH LOCALLY ADVANCED OR METASTATIC NON-SQUAMOUSNON-SMALL CELL LUN
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated